The biotechnology bubble machine

Article Abstract:

The biotechnology industry is one of the most research-intensive industries in the world and has more than tripled in size since 1992. Amgen's Epogen and Neupogen, which produce more red and white cells respectively, are biotechnology's most moneymaking drugs.

Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Product introduction, Pharmaceutical Preparation Manufacturing, Commodity & service prices, New Products/Services, Management dynamics, Pharmaceutical preparations, Metabolic Agents NEC, Metabolic Agents, Molecular Biological Products, Research, Management, Product development, Biotechnology industry, Biotechnology industries, Drugs, Prices and rates, Company business management, Biotechnology, Company pricing policy, Amgen Biologicals/Diagnostics

---

Comples biology with no parameters

Article Abstract:

Biology research has changed form dissection to system integration with the publication of analyses of the human genome sequence.

Research and Development in the Physical, Engineering, and Life Sciences, Biology

---

Protein function in the post-genomic era

Article Abstract:

Functional genomics poses the question, How will we use the sequencing data we have so much of at this point?

Similar abstracts:

• Abstracts: That other pension problem. Pension perils. Still on hols
• Abstracts: Are you making a good impression? Out with the count. A pressing issue
• Abstracts: New technology rolls in with the real millennium. TV and PC battle brews over consumer snapshot viewing. Color management wars aren't over - here comes the Web
• Abstracts: Determining reasonable compensation: a review of Alpha Medical and other recent decisions. Tax issues surrounding assisted reproduction expenses

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.